7,520.93

-29.01

-0.38%

52,231.89

-157.86

-0.30%

25,065.88

-187.26

-0.74%

2,821.38

-19.44

-0.68%

4.9830

+0.1190

+2.45%

19.46

-0.46

-2.31%

4,047.00

+16.80

+0.42%

73,626.26

-1,356.42

-1.81%

Crude Oil Dec 26

86.25

+0.21

+0.24%

US Private Equity

10,850.15

0.00

0.00%

Frankfurt - Delayed Quote EUR

WASGAU Produktions & Handels AG (MSH.F)

9.40 +1.25 (+15.34%)

At close: November 10 at 9:44:42 AM GMT+1

How IBD Stock Of The Day TG Therapeutics Is Catching Up To Roche, Novartis

Investor's Business Daily 2h ago

TGTX

ROP.SW

NVS
PepGen Stock Spikes 132% on Rare-Disease Win. These Rivals Are Feeling The Pressure.

Barrons.com 5h ago

PEPG

ARWR

DYN
PepGen Stock Doubles in One Session - Here's Why

Benzinga 5h ago

PEPG

DYN

NVS
INFORMATION REGARDING THE TOTAL VOTING RIGHTS AND SHARES OF KLÉPIERRE SA AS OF OCTOBER 31, 2026

GlobeNewswire 6h ago

LI.PA
Novartis ianalumab two-year data at ACR show further improvements in Sjögren’s disease activity

GlobeNewswire 7h ago

NVS

68CT
Former Novartis CEO on What AI Can’t Replace in the Workplace

WSJ 7h ago

NVS
IMVIONIX Acquires U.S. and Canadian Rights to BEOVU® (brolucizumab-dbll), Marking the Company's Official Launch

PR Newswire 10h ago

NVS
Personalized Medicines - Global Strategic Business Report 2026: Capitalize on the $496.6B Market by 2032 | Competitive Intelligence on Roche, Novartis, Abbott Molecular and QIAGEN

GlobeNewswire 10h ago

ROP.SW

NVS

QGEN
Exmar (ENXTBR:EXM) Stock May Be Fully Valued On Steady Cash Flow Assumptions

Simply Wall St. 10h ago

EXM.BR
Novartis ranks first place in 2026 Access to Medicine Index

GlobeNewswire 11h ago

NVS

68CT
Zacks Industry Outlook Highlights Eli Lilly, Novartis and Bayer

Zacks 18h ago

LLY

BAYN.DE

NVS
European Stocks Close Higher in Monday Trading Amid Easing Bond Yields, Oil Prices

PREMIUM
MT Newswires 1d ago

NVS

CL=F

^STOXX

Mobilize your Website

View Site in Mobile | Classic

Share by: